EX-99.1 2 tm2521314d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

 

   Date   Principal   Aggregated
Principal		 
Original Secured Promissory Note   11/10/2022   $2,319,279   $2,319,279 
Additional Loans to be included:               
               Loans #1 dated 12/22/2022 through Loan #26 dated 12/12/2024       $4,625,000   $6,944,279 
               Loan #27   1/13/2025   $125,000   $7,069,279 
               Loan #28   1/23/2025   $100,000   $7,169,279 
               Loan #29   2/03/2025   $125,000   $7,294,279 
               Loan #30   2/14/2025   $100,000   $7,394,279 
               Loan #31   2/28/2025   $100,000   $7,494,279 
               Loan #32   3/17/2025   $100,000   $7,594,279 
               Loan #33   4/04/2025   $100,000   $7,694,279 
               Loan #34   4/18/2025   $100,000   $7,794,279 
               Loan #35   5/02/2025   $100,000   $7,894,279 
               Loan #36   5/22/2025   $100,000   $7,994,279 
               Loan #37   6/03/2025   $100,000   $8,094,279 
               Loan #38   6/20/2025   $100,000   $8,194,279 
               Loan #39   7/03/2025   $100,000   $8,294,279 
               Loan #40   7/18/2025   $100,000   $8,394,279 

 

ACURA PHARMACEUTICALS, INC.  

 

By: /s/ Robert A. Seiser   
Robert A. Seiser  
Senior Vice President & CFO  
Date: July 21, 2025